These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression. Lineham A; Avila-Quintero VJ; Bloch MH; Dwyer J J Child Adolesc Psychopharmacol; 2023 Feb; 33(1):20-26. PubMed ID: 36799961 [No Abstract] [Full Text] [Related]
3. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH Focus (Am Psychiatr Publ); 2022 Apr; 20(2):241-251. PubMed ID: 37153136 [TBL] [Abstract][Full Text] [Related]
5. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095 [TBL] [Abstract][Full Text] [Related]
6. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139 [TBL] [Abstract][Full Text] [Related]
7. Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]). Jelovac A; McCaffrey C; Terao M; Shanahan E; Mohamed E; Whooley E; McDonagh K; McDonogh S; Igoe A; Loughran O; Shackleton E; O'Neill C; McLoughlin DM BMC Psychiatry; 2023 Nov; 23(1):850. PubMed ID: 37974160 [TBL] [Abstract][Full Text] [Related]
8. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Green CE; Perez AM; Iqbal S; Pillemer S; Foulkes A; Shah A; Charney DS; Mathew SJ Am J Psychiatry; 2013 Oct; 170(10):1134-42. PubMed ID: 23982301 [TBL] [Abstract][Full Text] [Related]
9. A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation. Su TP; Li CT; Lin WC; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC; Chen LF; Li WC; Chen MH Int J Neuropsychopharmacol; 2023 May; 26(5):331-339. PubMed ID: 36966411 [TBL] [Abstract][Full Text] [Related]
10. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression. Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA Neural Plast; 2015; 2015():858251. PubMed ID: 26137324 [TBL] [Abstract][Full Text] [Related]
11. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378 [TBL] [Abstract][Full Text] [Related]
12. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P; BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236 [TBL] [Abstract][Full Text] [Related]
13. Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions. Ryan K; Hosanagar A Curr Psychiatry Rep; 2023 Aug; 25(8):337-344. PubMed ID: 37389787 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528 [TBL] [Abstract][Full Text] [Related]
15. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. Reif A; Bitter I; Buyze J; Cebulla K; Frey R; Fu DJ; Ito T; Kambarov Y; Llorca PM; Oliveira-Maia AJ; Messer T; Mulhern-Haughey S; Rive B; von Holt C; Young AH; Godinov Y; N Engl J Med; 2023 Oct; 389(14):1298-1309. PubMed ID: 37792613 [TBL] [Abstract][Full Text] [Related]
16. Ketamine and other glutamate receptor modulators for depression in adults. Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901 [TBL] [Abstract][Full Text] [Related]